Bancorp International Group Inc (fka BCIT) : Were are they? In the hands of Mr. Megas...

f1fans · 2012-04-25T22:28:22.6670000Z

Were are they? In the hands of Mr. Megas ready to turn in when the DTC or SEC is ready for them. Please read CarltonH's post and you would have known this. F1

Play Episode

7min

Proactive - Interviews for investors

Eclipse Metals secures uranium partnership

Eclipse Metals Ltd (ASX:EPM) executive chairman Carl Popal talked with Proactive about the company’s earn-in agreement with Boss Energy Ltd to advance exploration at the Liverpool Uranium Project in the Northern Territory’s Alligator Rivers Uranium Field. Popal described the deal as a “game changer” that brings funding, technical expertise, and an experienced uranium producer into the project. The agreement allows Boss Energy to earn up to 80% ownership in stages by funding exploration work, with an initial commitment this year followed by further investment. Discussing the potential of the Devil’s Elbow prospect, Popal highlighted its geological similarities to the high-grade Jabiluka deposit. He emphasisd that the project has strong uranium, palladium, and gold mineralisation, with deep drilling planned to explore its full potential. Beyond uranium, Eclipse Metals is advancing its Greenland rare earths projects, with key metallurgical results expected soon. The company is optimistic that its assets, including a large carbonatite deposit, could be significant in the rare earths sector. Watch the full interview to learn more about Eclipse Metals' uranium and critical minerals strategy. Don’t forget to like the video, subscribe to Proactive’s YouTube channel, and turn on notifications for future updates. #EclipseMetals #ASX #ProactiveInvestors #BossEnergy #Uranium #Mining #Investing #RareEarths #Exploration #UraniumStocks #Greenland #CriticalMinerals #Jabiluka #DevilsElbow #StockMarket #Energy

Proactive - Interviews for investors

Helix Exploration expands with key acquisition at Rudyard

HeLIX Exploration PLC (AIM:HEX) CEO Bo Sears talked with Proactive's Stephen Gunnion about the company’s latest expansion at its Rudyard Project in Montana. Sears highlighted the acquisition of the Weil #1 well and its surrounding 640-acre section, which effectively doubles Helix's production capacity. The purchase, completed for $300,000, presents significant value compared to the estimated $1.3 million cost of drilling a new well. Sears explained that Rudyard’s helium potential has been known since Texaco’s 1960 drilling, but only recently has its full scale been realised. With ongoing development, Helix is transitioning from an exploration-focused approach to a development drilling program, significantly reducing risks in future wells. The company is also preparing to spud the Linda #1 well in April, pending regulatory approvals. Additionally, Sears confirmed that the Darwin #1 well is ready for production as soon as the necessary plant infrastructure is in place. On the Ingomar project, he noted that while initial gas samples were noncommercial, future drilling in the Flathead formation is planned after environmental restrictions lift in mid-June. Stay tuned to Proactive for more updates from Helix Exploration. If you found this video helpful, give it a like, subscribe to our channel, and turn on notifications for future updates. #Helium #HelixExploration #EnergySector #OilAndGas #Drilling #Investment #NaturalResources #EnergyStocks #Montana #Exploration #Mining #StockMarket

Proactive - Interviews for investors

Solvonis Therapeutics strengthens board with addition of Dr Renata Crome

Solvonis Therapeutics PLC (LSE:SVNS) non-executive director-elect Dr Renata Crome talked with Proactive about her appointment to the board and what she brings to the company. Dr Crome has an extensive background in pharmaceutical development, having worked at Roche for 30 years. She played a key role in the development of blockbuster treatments such as bevacizumab and obinutuzumab for cancer, as well as Tamiflu for influenza. Following her time at Roche, she transitioned to board roles across commercial and charity organisations and also lectures in pharmaceutical medicine. Discussing her contributions to Solvonis, Dr Crome highlighted her strategic expertise and experience in central nervous system (CNS) treatments. "I have extensive experience in developing treatments in the central nervous system area, and I know the challenges and some of the solutions," she said. She also emphasised her ability to leverage a strong network of experts to support the company's goals. Dr Crome expressed enthusiasm for Solvonis' innovative pipeline and differentiated treatments, as well as the strength of its leadership team. "It’s a privilege to be invited to join them," she said. For more interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future content. #SolvonisTherapeutics #Pharmaceuticals #Biotech #HealthcareInnovation #Leadership #CNSResearch #DrugDevelopment #Investing #Biopharma #ExecutiveLeadership

Proactive - Interviews for investors

NSX CEO highlights mining focus & direct listings as key growth drivers for 2025

National Stock Exchange of Australia CEO Max Cunningham talked with Proactive's Angela Harmantas from the PDAC conference in Toronto about the exchange’s role in the Australian market, its focus on mining companies, and its expansion plans. Cunningham explained that the NSX is one of two active stock exchanges in Australia with a tier-one license, allowing it to serve all investors, including retail. He highlighted that around one-third of the exchange’s listings are mining-related, with strong growth potential in the sector. Cunningham noted that NSX is working to fill a gap in the Australian venture market and is focusing on attracting mining companies, especially from regions like Perth. He also emphasized the importance of international relationships, mentioning cross-listing agreements with Canadian exchanges such as the CSE and TSX, as well as OTC Markets. Looking ahead to 2025, Cunningham discussed the challenges of IPOs due to regulatory hurdles and capital-raising difficulties. Instead, the NSX is prioritizing direct listings, which allow companies to go public without raising capital upfront. He stated that NSX is seeing increased interest from firms moving from the incumbent Australian exchange, as well as from Canadian companies seeking dual listings. #NSX #StockMarket #MiningStocks #IPOs #DirectListings #PDAC2025 #Investing #AustralianMarkets #DualListings #CapitalMarkets

Followers	26
Posts	4062
Boards Moderated	0
Alias Born	08/09/2005

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Go Ad-Free